Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer [Phase 1]
Phase 1 trial evaluating durvalumab and tremelimumab with radiotherapy in recurrent or metastatic gynecologic cancers has been terminated; n…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of CD70-targeted CAR-T therapy for CD70-positive advanced/metastatic solid tumors is currently recruiting, with potential indi…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project [NA]
The GRACE Project, a Rutgers-led study on genetic risk assessment for cancer education and empowerment in breast and ovarian cancer, has com…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer [Phase 3]
A Phase 3 trial comparing SHR-A1811 with chemotherapy for platinum-resistant recurrent epithelial ovarian cancer is currently not yet recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 study of SHR-A1811 Injection for platinum-sensitive recurrent ovarian cancer is listed, with the trial status not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reports termination of the NM21-1480 study in adults with advanced solid tumors, including non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Status update on ONC-392 showing safety, pharmacokinetics, and preliminary efficacy in monotherapy and in combination with anti-PD-1 across …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a PARP inhibitor combined with a CTLA-4 blocker in BRCA-deficient ovarian cancer, including fallopian tu…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer [Phase 2]
An ongoing Phase 2 study evaluating pembrolizumab in combination with chemotherapy for platinum-sensitive recurrent low-grade serous ovarian…
-
CLINICAL_TRIALS withdrawal · 2025-05-23Clinical Trial Update: Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer [Phase 1, Phase 2]
Withdrawal notice for a Phase 1/Phase 2 trial of Niraparib with selenium in BRCA-negative, platinum-resistant fallopian tube, ovarian, and p…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer [Phase 1]
A Phase 1 trial of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis [Phase 1]
Phase 1 study evaluating nivolumab with or without ipilimumab in patients with recurrent or high-grade gynecologic cancers and metastatic pe…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors [Phase 1]
A Phase 1 trial is evaluating the addition of Elimusertib, an ATR inhibitor, to gemcitabine for advanced pancreatic and ovarian cancers and …
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study evaluating MNPR-101-DFO*-89Zr as a diagnostic imaging agent for adults with various…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies [Phase 1]
Phase 1 study of COM902, a TIGIT inhibitor, in patients with advanced malignancies is ongoing and currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients [NA]
A completed clinical trial evaluated post-operative intravenous ketorolac for GTPase inhibition in ovarian cancer patients. The study also i…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
A clinical trial update describing a laboratory study of cancer and immune cells in ascites fluid from ovarian cancer patients to test alter…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients. [Phase 4]
A Phase 4 study investigating relationships between clinical, biological, and pharmacokinetic metrics and toxicities in ovarian cancer patie…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial evaluating total neoadjuvant chemotherapy for 6 cycles versus 3 cycles in partial responders with epithelial ovarian cancer; t…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy Detection
A completed trial evaluating IOTA ultrasound criteria combined with serum CA-125 for detecting ovarian malignancy. The study is sponsored by…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) [NA]
A clinical trial named PRESERVE is evaluating perioperative stress reduction versus standard of care in patients with ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer [Phase 2]
Phase II single-arm study evaluating Etigilimab (OMP-313M32) with nivolumab in platinum-resistant, recurrent epithelial ovarian cancer; the …
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Transforming Ovarian Cancer Diagnostic Pathways
This document reports ongoing recruitment for a clinical trial aimed at transforming diagnostic pathways for ovarian cancer.